ARTHQ (Arch Therapeutics) OCF Margin %: -2,941.94% (As of Jun. 2024)


ARTHQ Arch Therapeutics Inc ARTHQ
12 GF Score
Price $0.00
View Full Analysis

What is Arch Therapeutics OCF Margin %?

Arch Therapeutics ARTHQ -99.00% 12 OCF Margin % is -2,941.94% as of Jun. 2024. GuruFocus rates ARTHQ with a GF Score™ of 12/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Arch Therapeutics's Cash Flow from Operations for the three months ended in Jun. 2024 was $-0.91 Mil. Arch Therapeutics's Revenue for the three months ended in Jun. 2024 was $0.03 Mil. Therefore, Arch Therapeutics's OCF Margin % for the quarter that ended in Jun. 2024 was -2,941.94%.

As of today, Arch Therapeutics's current OCF Yield % is -97,000.00%.

The historical rank and industry rank for Arch Therapeutics's OCF Margin % or its related term are showing as below:

ARTHQ' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -2484.56

ARTHQ's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs ARTHQ: -2484.56

Arch Therapeutics OCF Margin % Related Terms

Arch Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Arch Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Therapeutics OCF Margin % Chart

Arch Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -49,658.33 -27,850.00 -4,439.47

Arch Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,907.69 -3,067.50 -1,876.09 -2,187.50 -2,941.94

ARTHQ vs GRTSQ, MTEM, PXMD: OCF Margin % Comparison

For the Biotechnology subindustry, Arch Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Arch Therapeutics's OCF Margin % falls into.


ARTHQ
12GF Score
Arch Therapeutics Inc ARTHQ
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Arch Therapeutics's OCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-3.374/0.076
=-4,439.47 %

Arch Therapeutics's OCF Margin for the quarter that ended in Jun. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.912/0.031
=-2,941.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -2,941.94% mean?
Arch Therapeutics (ARTHQ) has a OCF Margin % of -2,941.94% as of Jun. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Arch Therapeutics and its competitors.
Is Arch Therapeutics' OCF Margin % too high?
Arch Therapeutics' current OCF Margin % is -2,941.94%. Overall, Arch Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Arch Therapeutics' OCF Margin % compare to GRTSQ and MTEM?
Arch Therapeutics' OCF Margin % of -2,941.94% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Arch Therapeutics and its competitors. Arch Therapeutics's current OCF Margin % is -2,941.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Therapeutics stock overvalued right now?
Arch Therapeutics (ARTHQ) has a current OCF Margin % of -2,941.94%. The current OCF Margin % is -2,941.94%. Arch Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Arch Therapeutics (ARTHQ), the current OCF Margin % is -2,941.94% as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Therapeutics Business Description

Address 235 Walnut Street, Suite 6, Framingham, MA, USA, 01702
Arch Therapeutics Inc is a development-stage biotechnology company. It focuses on developing products that manage surgery and interventional care faster and safer by using a novel approach to stop bleeding, control leaking, and provide other advantages during surgery and trauma care. The company's primary product candidate, collectively known as the AC5 Devices (AC5), is designed to achieve hemostasis in surgical procedures. The company operates its business operations in the United States.
12GF Score

Get the complete analysis for ARTHQ

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price